Value Investing

Value Investing Articles

Exxon Mobil is one of the top oil and gas players in the world, and investors need to be considering how they should evaluate the company ahead.
Some down and out stocks don't always stay down, and sometimes great turnarounds and recoveries can create huge victories for opportunistic and visionary investors.
It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately, most of these are currently projected to deliver a solid 2018.
Two more companies were just added to the prized Merrill Lynch US 1 list, and those additions were made several after the firm's preliminary top 11 stocks for 2018 were released.
After a failed merger that crushed its stock, Rite Aid may never be able to get back to its highs of recent years, now that it has been shrinking its footprint. Or is that view false?
One thing that stood out after Buffett showed which stocks he has been buying and selling lately is that all the major stocks he held were trading under their consensus analyst price targets.
While these eight stocks are not being touted as Credit Suisse's formal top picks for 2018, the timeline sure sets them up to be among the top contenders.
Here are nine very speculative outside analyst calls looking for huge upside from the week of November 3, 2017. Conservative investors need to be more than just a little careful here.
Here are 13 featured spin-offs already underway and potential spin-offs that could be seen in 2017 and into 2018 that could radically change how Wall Street and Main Street evaluate companies ahead.
Here are 10 highly speculative analyst calls made by various Wall Street and boutique firm analysts with huge upside projections made during the week of October 20, 2017.
Sometimes it turns out that great growth companies eventually run into the day when getting the growth of the past is not possible. That has been the case of Gilead Sciences since 2015.
The week of September 30 has come to an end, and there were several major corporate developments this week that investors simply should not ignore or overlook.
It is no secret that investors love collecting dividends from their investments. Here are 15 entities that have payouts with yields or yield equivalents of 10% or more.
Here are 10 of the most notable top picks from Credit Suisse in European equities for U.S. investors.
The one trend in companies that have lost control of their narratives is that short sellers have continued to keep very negative views of the companies. Even those few that might be staging a...